Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

T2R43 Inhibitors

The human taste receptor T2R43 is one of the many G-protein coupled receptors (GPCRs) in the taste receptor type 2 family, which is primarily responsible for the bitter taste perception. These receptors are expressed on the surface of taste receptor cells found within the taste buds of the tongue and are involved in the detection of a wide range of bitter compounds. T2R43, like other taste receptors, plays a crucial role in the gustatory system, influencing dietary choices and food intake by signaling the presence of potentially harmful substances that often taste bitter. The expression of T2R43, as with other genes, is tightly regulated at the transcriptional level, which determines the amount of receptor protein produced within the cells. Understanding the regulation of T2R43 expression is significant for elucidating the intricate network of taste perception and its underlying molecular mechanisms. Several chemicals have been posited to have the potential to inhibit the expression of T2R43, acting through diverse biochemical pathways. Compounds such as sodium butyrate and Trichostatin A are known to exert their effects epigenetically by inhibiting histone deacetylases, which can lead to changes in chromatin structure and subsequently reduce gene expression. DNA methyltransferase inhibitors like 5-Azacytidine could downregulate T2R43 by inducing hypomethylation of gene regulatory sequences, thereby silencing gene activity. Other compounds, such as retinoic acid, affect gene expression by interacting with nuclear hormone receptors, which then bind to specific DNA sequences, possibly leading to a decrease in T2R43 expression. Additionally, small molecule inhibitors targeting intracellular signaling pathways-like the mTOR inhibitor rapamycin, the adenylate cyclase activator forskolin, and various kinase inhibitors (e.g., LY294002 and PD98059)-could also alter the expression of T2R43 by modulating the activity of transcription factors and the phosphorylation state of proteins involved in gene regulatory networks. These compounds, by interacting with different components of the cellular machinery, could potentially lead to reduced expression of T2R43, providing insight into the complex regulation of this bitter taste receptor.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$30.00
$46.00
$82.00
$218.00
19
(3)

Sodium butyrate may downregulate T2R43 by inhibiting histone deacetylases, leading to tighter chromatin packing and reduced transcriptional activity at the T2R43 gene locus.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound could decrease T2R43 expression through DNA demethylation, which may silence gene transcription by altering the epigenetic status of the T2R43 promoter region.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

By specifically inhibiting histone deacetylase, Trichostatin A may downregulate T2R43 by changing the acetylation state of histones associated with the gene, affecting its expression.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Retinoic acid may decrease T2R43 expression by binding to retinoic acid receptors that heterodimerize with retinoid X receptors, which then bind to retinoic acid response elements in the gene's promoter.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin could inhibit T2R43 expression by blocking mTOR signaling which is crucial for protein synthesis and cell growth, leading to a reduction in overall protein expression levels.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin may reduce T2R43 expression by elevating intracellular cAMP, which activates protein kinase A and leads to changes in the phosphorylation of transcription factors that govern T2R43 gene transcription.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$35.00
$115.00
$515.00
26
(1)

As a Wnt/β-catenin pathway inhibitor, XAV939 could downregulate T2R43 by preventing β-catenin from translocating to the nucleus and activating T-cell factor/lymphoid enhancer factor transcription of the gene.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY 294002 may inhibit T2R43 by blocking PI3K, which is instrumental in the Akt signaling pathway that can promote transcriptional activity of various genes, including potentially T2R43.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD 98059 may reduce T2R43 expression by inhibiting MEK, which is part of the MAPK/ERK pathway that regulates gene expression by controlling the activity of transcription factors.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

This NF-κB inhibitor could decrease T2R43 expression by preventing NF-κB from binding to DNA and initiating transcription of target genes, which may include T2R43.